Clinical Trial: Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545226) titled 'Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.' on April 16.

Brief Summary: The primary objective of this trial is to evaluate the pharmacokinetics (PK) of two evolocumab drug products in healthy participants.

Study Start Date: April 20

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Evolocumab Drug Substance A (Test)

Evolocumab drug substance A will be administered SC.

DRUG: Evolocumab Drug Substance B (Reference)

Evolocumab drug substance B will be administered SC.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ...